Rare diseases
Investigational molecules
Locations
706 conditions with trials, the busiest first
3 926 trials across Europe, recruiting first
Study on Tebentafusp and Drug Combination for Patients with Advanced Uveal Melanoma
BelgiumStudy of Pembrolizumab, Pemetrexed, and Carboplatin for Patients with Advanced Stage Non-Small Cell Lung Cancer (NSCLC)
The NetherlandsStudy on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver
BelgiumStudy of Regorafenib and Avelumab for Adults with Advanced or Metastatic Solid Tumors
FranceStudy on DF1001, Nivolumab, and Paclitaxel for Patients with Advanced Solid Tumors
BelgiumStudy on Mirvetuximab Soravtansine and Carboplatin for Patients with Recurrent Ovarian Cancer Eligible for Platinum-Based Chemotherapy
GermanyStudy on Using Cetuximab with Fluorescence Endoscopy to Find Primary Tumors in Patients with Unknown Head and Neck Cancer
The NetherlandsStudy of NBTXR3 and Cetuximab with Radiotherapy for Elderly Patients with Advanced Head and Neck Cancer Not Eligible for Platinum Chemotherapy
CzechiaStudy on Nivolumab with Drug Combination for Patients with Intermediate Stage Liver Cancer
FranceStudy on [18F]-Fludarabine and Gadoteric Acid for Imaging in Patients with Newly Diagnosed Primary CNS Lymphoma
FranceStudy on Trastuzumab Deruxtecan for Patients with Metastatic HER2-Positive Breast Cancer
ItalyStudy of Pembrolizumab for Patients with Recurrent, Platinum-Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
ItalyThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
